The SOMA (Subjective, Objective, Management, Analytic) – LENT (Late Effects of Normal Tissue) scoring system can be used to evaluate a patient with cerebral complication following radiation and chemotherapy.
Subjective measures:
(1) headache
(2) somnolence
(3) intellectual deficit
(4) functional competence
(5) memory
Objective measures:
(1) neurologic deficit in the irradiated part of the brain
(2) cognitive functions
(3) mood and personality changes
(4) seizures
Management measures:
(1) headaches, somnolence
(2) seizures
(3) cognition, memory
Analytic studies:
(1) MRI (see table below)
(2) neuropsychologic (see table below)
(3) CT: assessment of swelling, edema, atrophy
(4) MRS: assessment of chemical spectra
(5) PET scan: assessment of metabolic activity
(6) serum myelin basic protein levels
(7) CSF for total protein and myelin basic protein levels
If no toxicity is present, then the 0 points are assigned.
If a toxicity is present, then the grade indicates the number of points to assign.
|
Grade 1 |
Grade 2 |
Grade 3 |
Grade 4 |
headache |
occasional and minimal |
intermittent and tolerable |
persistent and intense |
refractory and excruciating |
somnolence |
occasional, able to work or perform normal activity |
intermittent, interferes with work or normal activity |
persistent; needs some assistance with self-care |
refractory; prevents daily activity; coma |
intellectual deficit |
minor loss of ability to reason and judge |
moderate loss of ability to reason and judge |
major loss in ability to reason and judge |
complete loss of reasoning and judgment |
functional competence |
perform complex tasks with minor inconvenience |
cannot perform complex tasks |
cannot perform simple tasks |
incapable of self-care; supervision; coma |
memory |
decreased short term; difficulty with learning |
decreased long term, loss of short term |
loss of short and long term |
complete disorientation |
neurologic deficit in irradiated brain |
barely detectable neurologic signs; able to perform normal activities |
easily detectable neurologic abnormalities; interferes with normal activities |
focal motor signs, disturbances in speech, vision, etc.; interferes with daily activities |
hemiplegia, hemisensory deficit, aphasia, blindness, coma; requires continuous care |
cognitive function |
minor loss of memory, reason and/or judgment |
moderate loss of memory, reason and judgment |
major intellectual impairment |
complex memory loss and/or incapable of rational thought |
mood and personality changes |
occasional and minor |
intermittent and minor |
persistent and minor |
total disintegration |
seizures |
focal, without impairment of consciousness |
focal with impaired consciousness |
generalized, tonic-clonic or absence attack |
uncontrolled with loss of consciousness > 10 minutes |
management of headache |
occasional non-narcotic medication |
persistent non-narcotic medication; intermittent low dose steroids |
intermittent high dose steroids |
parenteral high dose steroids, mannitol and/or surgery |
management of seizures |
behavioral modification |
behavioral modification and occasional oral medication |
permanent oral medication |
intravenous anti-convulsant medication |
management of cognition and memory |
minor adaptation |
psychosocial and educational intervention |
occupational and physical therapy |
custodial care |
total score =
= SUM(points for all 12 items)
LENT score =
= (total score) / 12
Analytical |
Grade 1 |
Grade 2 |
Grade 3 |
Grade 4 |
MRI findings |
focal white matter changes; dystrophic cerebral calcification |
white matter changes affecting <= 1 cerebral lobe; limited perilesional necrosis |
focal necrosis with mass effect |
pronounced white matter changes; mass effect requiring surgical intervention |
neuro-psychologic |
minor deficits in memory, IQ and/or attention |
IQ decrease 10 - 19 points |
IQ decrease 20 – 29 points |
>= 30 point decrease in IQ, but can learn simple tasks |
Interpretation:
• maximum total score: 48
• minimum LENT score: 0
• maximum LENT score: 4.0
• maximum analytical score: 8
Specialty: Hematology Oncology, Neurology